Health Economics

A groundbreaking advancement in hematology has been the introduction of chimeric antigen receptor (CAR) T-cell therapy, markedly improving survival rates among those battling hematological...

On November 14th, EUCOPE and FTI Consulting EU convened a pivotal event titled What Drives Life Sciences Investment in the EU and the Future...

In an era where industrial technology accelerates at an unprecedented pace, the intersection of environmental change and public health has become a pressing concern...

Thai students face significant challenges when commuting to school, which potentially impacts their health. A comprehensive study comprising 25,461 students aged 9 to 18...

Key TakeawaysEXBLIFEP addresses a critical gap in treating antibiotic-resistant infections. Cost-effectiveness may vary based on infection severity and patient demographics. Strict usage guidelines...

Key TakeawaysPrevention and screening are more effective than treatment alone in reducing mortality for most studied cancers. Smoking cessation remains the most impactful...

Key TakeawaysOver 50 products may require JSCs in 2025, far exceeding the planned 5-7 slots. Small to mid-sized companies, which are pivotal in...

Key TakeawaysHealthcare providers can streamline the distribution of Marstacimab. Patients may experience quicker access to necessary treatments. The decision may reduce bureaucratic overhead...

Key TakeawaysEstimated patient population indicates a moderate demand within the GKV system. Cost analysis highlights significant financial considerations for widespread adoption. Reserve antibiotic...

Key TakeawaysEnsures studies reflect the German patient population Enhances the relevance of clinical trial data for the local market May increase the administrative...

Inpatient rehabilitation facilities (IRFs) play a pivotal role in enhancing the functionality of individuals requiring post-acute care. Despite their potential benefits, particularly for cancer...

In a world increasingly interconnected through trade and commerce, market access remains a pivotal topic, especially within the global health sector. The recent article...

Key Takeaways • Tirzepatide demonstrated a 21% average body weight reduction in clinical trials. • The initial rollout is expected to benefit around 220,000 people. • NHS...

Europe stands at a pivotal moment as biologic drugs approach the end of their market exclusivity, presenting a significant opportunity to enhance healthcare access...

The latest Maternal Health Equity Data Brief reveals concerning trends in maternal health among Medicaid and CHIP enrollees aged 15 to 49. Analyzing data...